Filter
4125
Filtered Results: 4125
Text search:
Analysis
and
Perspectives
Featured
Recommendations
255
New Publications
953
Language
Document type
No document type
2276
Studies & Reports
924
Guidelines
434
Manuals
202
Strategic & Response Plan
158
Fact sheets
47
Training Material
46
Situation Updates
20
Resource Platforms
13
Infographics
4
Brochures
1
Countries / Regions
Global
200
India
105
Western and Central Europe
97
Kenya
85
Latin America and the Carribbean
85
Myanmar / Burma
80
Ethiopia
74
South Africa
74
Nepal
68
Sierra Leone
67
Liberia
62
Africa
62
Nigeria
57
Uganda
57
Syria
56
Zambia
52
Bangladesh
52
Malawi
51
Senegal
44
Congo, Democratic Republic of
44
Rwanda
44
Ghana
39
Indonesia
37
Tanzania
34
Eastern Europe
34
Brazil
32
Ukraine
32
Guinea
30
Zimbabwe
27
Mozambique
26
Colombia
26
Philippines
23
Russia
23
South–East Asia Region
22
Burkina Faso
21
Haiti
21
South Sudan
21
Germany
21
East and Southern Africa
21
Asia
21
Namibia
20
Cameroon
19
Benin
19
Lesotho
19
Venezuela
19
Cambodia
18
Middle East and North Africa
18
West and Central Africa
17
Yemen
14
Eastern Europe and Central Asia
14
Afghanistan
13
Central African Republic
13
Argentina
13
Pakistan
12
Jordan
12
Lebanon
12
Thailand
12
Chile
11
Vietnam
11
Western Pacific Region
10
Somalia
9
Peru
9
Eswatini/ Swaziland
8
Botswana
8
Madagascar
8
Paraguay
8
Moldova
8
USA
7
China
7
Angola
7
Tajikistan
7
Niger
6
Turkey
6
Chad
6
Mali
5
Côte d’Ivoire / Ivory Coast
5
Egypt
5
Burundi
5
Ecuador
5
Laos
5
Spain
5
Iraq
4
Papua New Guinea
4
Sri Lanka
4
Albania
4
Iran
4
France
4
United Kingdom
4
Portugal
4
Guinea-Bissau
3
North Macedonia
3
Hungary
3
Bolivia
3
Mexico
3
Poland
3
Southern Africa
3
Romania
3
Kyrgyzstan
3
Georgia
3
North America
3
Japan
3
Togo
2
Malaysia
2
Singapore
2
Vanuatu
2
Serbia
2
Croatia
2
Honduras
2
El Salvador
2
Greece
2
Guatemala
2
Bhutan
2
Palestine
2
North Korea
2
Canada
2
Slovakia
2
Kazakhstan
2
Morocco
1
Gambia
1
Mauritania
1
Ireland
1
Dominican Republic
1
Libya
1
Fiji
1
Solomon Islands
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Bulgaria
1
Lithuania
1
Turkmenistan
1
Jamaica
1
Denmark
1
Mauritius
1
Norway
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
1264
Public Health
267
Clinical Guidelines
231
Key Resources
216
Women & Child Health
206
Capacity Building
66
Pharmacy & Technologies
23
Toolboxes
Mental Health
441
HIV
324
COVID-19
318
Disability
251
Planetary Health
248
TB
184
Caregiver
120
AMR
113
Global Health Education
111
Conflict
109
Ebola
99
NTDs
95
NCDs
95
Refugee
91
Rapid Response
82
Natural Hazards
51
Health Financing Toolbox
48
Social Ethics
41
Pharmacy
41
Specific Hazards
28
Polio
18
Zika
10
Cholera
9
Typhoon
4
Health Financing
2
South Sudan
1
Technical Assistance Report
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) ... the Model List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security ... safety, environmental effects on ecosystems and biodiversity, and socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”.
The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines.
Its strategic objectives include:
• improving the awareness and understanding of AMR;
• strengthening the knowledge and evidence base through surveillance and research;
• reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and
• developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions.
With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objectives
Draft Working Discussion Paper
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation ... dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The term "Programmatic Management of Drug Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices ... availability surveys. This second edition of the survey manual has been updated to reflect the wealth of practical
experience in conducting medicine prices and availability surveys garnered in the project’s first two phases.
This guide is an introduction on how to integrate logistics management information systems (LMIS) with geographic information systems (GIS). It covers the value of integrating these two systems, the steps in assessing if it is currently viable to link the systems, how to set the linkage, the process...
The Guide has been developed to enhance the knowledge capabilities of NDMAs and their local partners. This is accomplished by exposing them to the existing tools and services developed by the intern...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, poli...
A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current le...
The approach is in line with two of the five objectives outlined in the Every Newborn Action Plan (ENAP): Strategic Objective 2 – Improve the quality of maternal and newborn care; and Strategic Ob...
